View by Specialty

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 06, 2024
2 min read
Save

Bulk ordering, text messaging improve mammography completion rates

Bulk ordering, text messaging improve mammography completion rates

Bulk ordering and text messaging outreach significantly increased completion rates for mammography breast cancer screening, according to results of two randomized clinical trials published in JAMA Internal Medicine.

SPONSORED CONTENT
May 06, 2024
2 min read
Save

PCPs tied to cervical cancer screening adherence, regardless of sexual orientation

PCPs tied to cervical cancer screening adherence, regardless of sexual orientation

Having a primary care provider raises the likelihood of being up to date on cervical cancer screening, regardless of sexual orientation, but the association was greatest among lesbian, gay and bisexual women, according to researchers.

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

SPONSORED CONTENT
May 02, 2024
2 min read
Save

Increased childhood leukemia risk with embryo transfer vs. natural conception

Increased childhood leukemia risk with embryo transfer vs. natural conception

Children conceived via fresh or frozen embryo transfer may have increased risk for acute lymphoblastic leukemia compared with children conceived naturally, according to cohort study results published in JAMA Network Open.

SPONSORED CONTENT
May 01, 2024
1 min read
Save

FDA approves Hercessi as latest interchangeable Herceptin biosimilar

FDA approves Hercessi as latest interchangeable Herceptin biosimilar

The FDA has approved trastuzumab-strf as a biosimilar to trastuzumab for the treatment of certain patients with HER2-overexpressing malignancies, according to a press release from the agent’s manufacturer.

SPONSORED CONTENT
May 01, 2024
4 min read
Save

USPSTF: Women should be screened for breast cancer every other year starting at age 40

USPSTF: Women should be screened for breast cancer every other year starting at age 40

Women should be screened for breast cancer every other year starting at age 40 years, according to a new recommendation statement from the U.S. Preventive Services Task Force.

SPONSORED CONTENT
May 01, 2024
3 min read
Save

Tool may predict premature menopause among childhood cancer survivors

Tool may predict premature menopause among childhood cancer survivors

A multi-institutional team of researchers created a statistical model capable of predicting the risk for premature menopause among women who survived childhood cancer.

SPONSORED CONTENT
April 29, 2024
1 min read
Save

Enhertu delays disease progression in certain patients with metastatic breast cancer

Enhertu delays disease progression in certain patients with metastatic breast cancer

Compared with standard-of-care chemotherapy, trastuzumab deruxtecan demonstrated a statistically significant improvement in PFS among certain patients with metastatic breast cancer, according to a press release from the manufacturer.

SPONSORED CONTENT
April 29, 2024
3 min read
Save

‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse

‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse

Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.

SPONSORED CONTENT
April 24, 2024
2 min read
Save

Increased mortality risk for BRCA carriers diagnosed within 10 years postpartum

Increased mortality risk for <i>BRCA </i>carriers diagnosed within 10 years postpartum

Women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if diagnosis occurred within 10 years postpartum, according to cohort study results published in JAMA Network Open.

SPONSORED CONTENT
April 22, 2024
2 min read
Save

Neighborhood disadvantage linked to shorter breast cancer-specific, overall survival

Neighborhood disadvantage linked to shorter breast cancer-specific, overall survival

Women with breast cancer living in the most vs. the least disadvantaged neighborhoods had higher risks for breast cancer-specific and overall mortality, according to cohort study results published in JAMA Network Open.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails